{"title":"Drugdiag® Urine Test Cassette","description":"\u003csection class=\"ama-collection-description\"\u003e\n \u003ch2\u003eDrugdiag® Cassette Urine Tests for Drug Screening\u003c\/h2\u003e\n\n \u003cp\u003e\n The \u003cstrong\u003eDrugdiag® cassette urine tests\u003c\/strong\u003e offered by \u003cstrong\u003eAMA Prévention\u003c\/strong\u003e\n provide a simple, fast, and easy-to-read \u003cstrong\u003eurine drug screening\u003c\/strong\u003e.\n This format suits the needs of \u003cstrong\u003ebusinesses\u003c\/strong\u003e, \u003cstrong\u003ehealth professionals\u003c\/strong\u003e,\n \u003cstrong\u003eprevention organizations\u003c\/strong\u003e, \u003cstrong\u003ecommunities\u003c\/strong\u003e, and \u003cstrong\u003eindividuals\u003c\/strong\u003e\n seeking a reliable solution to detect various families of psychoactive substances.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Depending on the model, Drugdiag® cassette urine tests can detect\n \u003cstrong\u003eTHC\u003c\/strong\u003e, \u003cstrong\u003ecocaine\u003c\/strong\u003e, \u003cstrong\u003eopiates\u003c\/strong\u003e,\n \u003cstrong\u003eamphetamines\u003c\/strong\u003e, \u003cstrong\u003emethamphetamines\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e,\n \u003cstrong\u003ebenzodiazepines\u003c\/strong\u003e, \u003cstrong\u003emethadone\u003c\/strong\u003e, \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e,\n \u003cstrong\u003ebarbiturates\u003c\/strong\u003e, or \u003cstrong\u003etricyclic antidepressants\u003c\/strong\u003e,\n depending on the chosen reference.\n \u003c\/p\u003e\n\n \u003ch3\u003eDrugdiag® cassette: a precise, clear, and practical format\u003c\/h3\u003e\n\n \u003cp\u003e\n The \u003cstrong\u003eDrugdiag® cassette urine test\u003c\/strong\u003e is used after collecting a urine sample.\n Simply place a few drops into the test wells using the provided pipette.\n The reactive strips then display a visual result within minutes, with a clear reading directly on the device.\n \u003c\/p\u003e\n\n \u003cp\u003e\n This cassette format is especially appreciated for its \u003cstrong\u003eease of use\u003c\/strong\u003e,\n \u003cstrong\u003econtrolled cost\u003c\/strong\u003e, and ability to screen for multiple substances depending on the model.\n Some references allow multi-drug screening of up to \u003cstrong\u003e11 substances simultaneously\u003c\/strong\u003e,\n making it a suitable solution for prevention campaigns, professional needs, and occasional checks.\n \u003c\/p\u003e\n\n \u003ch3\u003eA range developed by a specialized French manufacturer\u003c\/h3\u003e\n\n \u003cp\u003e\n Drugdiag® urine tests are developed by \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, a French manufacturer specializing\n in rapid diagnostic tests. AMA Prévention selects these devices for their readability,\n ease of use, and suitability for both professional and personal use.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Depending on the references, some tests may feature specific characteristics or mentions,\n including \u003cstrong\u003eCE marking\u003c\/strong\u003e, manufacturing under applicable quality standards,\n the \u003cstrong\u003eAlsace Cœur label\u003c\/strong\u003e, or the mention \u003cstrong\u003eUsed by the French Armed Forces\u003c\/strong\u003e\n when applicable to the selected product.\n \u003c\/p\u003e\n\n \u003ch3\u003eUrine tests for businesses, health, prevention, and private use\u003c\/h3\u003e\n\n \u003cp\u003e\n \u003cstrong\u003eUrine drug screening tests\u003c\/strong\u003e are used in many contexts:\n workplace prevention, self-monitoring, license recovery, support in health facilities,\n awareness actions, internal monitoring, or occasional verification needs.\n They provide quick orientation tests, useful for obtaining an initial indication.\n \u003c\/p\u003e\n\n \u003cp\u003e\n In professional settings, the use of screening tests must be within a clear,\n proportionate framework and comply with applicable rules, especially when the positions involved\n pose particular safety risks. AMA Prévention supports businesses\n in choosing the most suitable references for their needs.\n \u003c\/p\u003e\n\n \u003ch3\u003eOrder your Drugdiag® cassette urine tests\u003c\/h3\u003e\n\n \u003cp\u003e\n Order your \u003cstrong\u003eDrugdiag® cassette urine tests\u003c\/strong\u003e, \u003cstrong\u003eTHC urine tests\u003c\/strong\u003e,\n \u003cstrong\u003emulti-drug urine tests\u003c\/strong\u003e, and professional screening devices directly\n online at AMA Prévention. Fast shipping within 24 hours with DPD, responsive customer service,\n and professional support to choose the test best suited to your situation.\n \u003c\/p\u003e\n\n \u003cp\u003e\n \u003cstrong\u003e\n For bulk orders, professional needs, or prevention campaigns,\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\"\u003erequest a personalized quote from AMA Prévention\u003c\/a\u003e.\n \u003c\/strong\u003e\n \u003c\/p\u003e\n\u003c\/section\u003e","products":[{"product_id":"test-urinaire-cassette-6-drogues","title":"6-Drug Urine Test Drugdiag® 6","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003e6-drug urine test\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® 6: professional multi-drug urine test\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n The \u003cstrong\u003eDrugdiag® 6 drugs urine test\u003c\/strong\u003e is a reliable, precise screening device compliant with medical requirements. Designed by the French laboratory \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, the leader in rapid diagnostic tests, it allows simultaneous detection of \u003cstrong\u003e6 families of psychoactive substances\u003c\/strong\u003e in urine.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n It targets the following families: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e cannabis, \u003cstrong\u003eCOC\u003c\/strong\u003e cocaine, \u003cstrong\u003eAMP\u003c\/strong\u003e amphetamines, \u003cstrong\u003eMET\u003c\/strong\u003e methamphetamines, \u003cstrong\u003eMOP\u003c\/strong\u003e opiates, and \u003cstrong\u003eBUP\u003c\/strong\u003e buprenorphine.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Recommended for professional, medical, institutional, or personal use, it fits into a structured prevention approach: employers, occupational health, healthcare facilities, addiction monitoring, sensitive positions, and responsible self-monitoring.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eSimultaneous detection of 6 families\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRapid-read urine format\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eHealth, workplace, and self-monitoring use\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetection\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 targeted families\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDetected substances\u003c\/h2\u003e\n\n \u003cp\u003e\n The Drugdiag® 6 urine test detects the 6 most frequently encountered families of psychoactive substances in professional, clinical, and preventive practice.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e urinary metabolite of THC, associated with consumption of cannabis, resin, flowers, or products containing THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e cocaine, crack, and related metabolites detectable in urine.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e amphetamine-type stimulants, speed, and related substances.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e crystal meth, ice, and related derivatives.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e morphine, heroin, opium, and related compounds.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e molecule used notably in certain opioid substitution treatments.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Thresholds must be interpreted according to the manufacturer's instructions, clinical or professional context, and screening objectives. A rapid positive result remains a preliminary result.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUses\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eBusiness, health, monitoring\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eMain uses\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eWorkplace prevention\u003c\/h3\u003e\n \u003cp\u003e\n In line with the spirit of article \u003cstrong\u003eL.4121-1 of the Labor Code\u003c\/strong\u003e, this test can be part of a risk prevention approach for safety and security positions: machinery operation, transport, construction, industry, private security, or sensitive sectors.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eMedical and addiction use\u003c\/h3\u003e\n \u003cp\u003e\n The Drugdiag® 6 urine test is relevant for healthcare professionals: withdrawal monitoring, addiction consultations, consumption control, and monitoring opioid substitution treatments thanks to the \u003cstrong\u003eBUP\u003c\/strong\u003e panel.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePersonal self-monitoring\u003c\/h3\u003e\n \u003cp\u003e\n It can be used for self-monitoring before an important deadline, a medical visit, resuming a sensitive position, or as part of a personal effort to reduce or stop consumption.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eAdvantages of the Drugdiag® 6 test\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eSimultaneous screening:\u003c\/strong\u003e 6 substance families tested in a single analysis.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eWide coverage:\u003c\/strong\u003e cannabis, cocaine, amphetamines, methamphetamines, opiates, and buprenorphine.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQuick result:\u003c\/strong\u003e simple visual reading in a few minutes according to the instructions.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFrench manufacturer:\u003c\/strong\u003e device from the Drugdiag® range by Toda Pharma laboratory.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eProfessional quality:\u003c\/strong\u003e CE certification and ISO 13485 quality environment.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSuitable for the Joana Plan:\u003c\/strong\u003e relevant for prevention efforts in companies and securing sensitive positions.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eVersatile use:\u003c\/strong\u003e health, business, institutions, and personal self-monitoring.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResults\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eUrine durations\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUrine detection times\u003c\/h2\u003e\n\n \u003cp\u003e\n The detection time in urine depends on many factors: frequency and amount of consumption, metabolism, hydration, kidney function, length of use, and potency of consumed products.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e indicative duration varies from 1 to 30 days depending on consumption profile.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 30 days\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e indicative urine detection generally between 1 and 4 days.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e indicative urine detection generally between 1 and 4 days.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e indicative urine detection generally between 1 and 4 days.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e indicative urine detection generally between 1 and 4 days.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e indicative detection duration generally between 1 and 7 days.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n These durations are indicative. They can vary greatly depending on metabolism, body mass index, kidney function, frequency of use, treatments followed, and concentration of consumed products.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eNegative result\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n A negative result indicates that the targeted substances were not detected above the test’s detection thresholds. This does not guarantee the absolute absence of any substance.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003ePositive result\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n A positive result indicates a reaction compatible with the presence of one or more targeted families in the urine. For any official, professional, medical, or disputed context, laboratory confirmation may be necessary.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eInvalid result\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be redone with a new device.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTechnique\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQuality and reliability\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTechnical expertise\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eColloidal gold technology\u003c\/h3\u003e\n \u003cp\u003e\n The device uses competitive immunochromatography with colloidal gold-labeled antibodies, allowing clear, rapid reading suitable for professional use.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eGC\/MS reliability\u003c\/h3\u003e\n \u003cp\u003e\n The accuracy of this professional urine screening device has been compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eQuality compliance\u003c\/h3\u003e\n \u003cp\u003e\n Designed by the French laboratory Toda Pharma, this \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is CE marked and complies with the quality environment standard \u003cstrong\u003eISO 13485\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eMain features\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTest type:\u003c\/strong\u003e rapid-read multi-drug urine test.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstances detected:\u003c\/strong\u003e THC-COOH, COC, AMP, MET, MOP, BUP.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e professional urinary device with visual reading.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUse:\u003c\/strong\u003e professional prevention, health, addiction monitoring, self-testing.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e French laboratory Toda Pharma, the number 1 in rapid diagnostic testing.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e in vitro medical diagnostic device with CE marking and ISO 13485.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eNo cross-reactivity\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eCommon medications:\u003c\/strong\u003e aspirin, ibuprofen, paracetamol, amoxicillin, penicillin, dextromethorphan.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003ePhysiological and dietary substances:\u003c\/strong\u003e caffeine, cholesterol, hemoglobin, creatinine, vitamin C, uric acid.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n The test must be used according to the manufacturer’s instructions. In case of a positive, doubtful, or disputed result, confirmation by laboratory analysis is still recommended.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eFAQ\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFrequently Asked Questions\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eWhat does the Drugdiag® 6 urine test detect?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n It detects 6 families of substances in urine: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003ecocaine\u003c\/strong\u003e, \u003cstrong\u003eamphetamines\u003c\/strong\u003e, \u003cstrong\u003emethamphetamines\u003c\/strong\u003e, \u003cstrong\u003eopiates\u003c\/strong\u003e, and \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eWhy is buprenorphine included?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Buprenorphine can be tested in certain medical or addiction contexts, especially during opioid substitution treatment monitoring.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eIs this test suitable for workplace use?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Yes, it can be part of a prevention approach in sensitive positions, respecting internal regulations, proportionality, confidentiality, and the applicable legal framework.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eHow long do drugs remain detectable in urine?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n The duration varies depending on the substance and profile. THC-COOH can remain detectable longer than other families, sometimes up to 30 days depending on consumption profiles.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eDoes a positive result have definitive value?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n No. A rapid test provides a preliminary result. For any official, disciplinary, medical, or disputed decision, confirmation by laboratory analytical method is recommended.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003eNeed advice or a quote for a professional order?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Request a quote\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eLegal notice:\u003c\/strong\u003e This \u003ci\u003ein vitro\u003c\/i\u003e diagnostic device is intended for professional or personal use, in compliance with current French and European legislation. It provides a preliminary analytical result. In judicial, disciplinary, medical, or disputed contexts, any positive result must be confirmed by laboratory analysis.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"Pack of 5","offer_id":56426433741124,"sku":"1046","price":59.5,"currency_code":"EUR","in_stock":true},{"title":"Pack of 10","offer_id":56426433773892,"sku":"1046","price":113.05,"currency_code":"EUR","in_stock":true},{"title":"Pack of 25","offer_id":56426433806660,"sku":"1046","price":252.88,"currency_code":"EUR","in_stock":true},{"title":"1 unit","offer_id":56426433708356,"sku":"1046","price":11.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_produit_du_drugdiag_6.png?v=1777888318"},{"product_id":"test-urinaire-thc","title":"THC (Cannabis) Urine Test Drugdiag®","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag THC urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eCannabis urine test\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® THC: cannabis urine test THC-COOH at 50 ng\/mL \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e The \u003cstrong\u003eDrugdiag® THC urine test\u003c\/strong\u003e is a professional screening device designed to detect \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, the main urinary metabolite of cannabis. Unlike saliva tests, which detect active THC over a short period, the urine test can identify older consumption. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Developed by \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, France’s leading rapid diagnostic test laboratory, this cannabis urine test offers a detection threshold calibrated at \u003cstrong\u003e50 ng\/mL\u003c\/strong\u003e. It is suitable for \u003cstrong\u003eself-testing\u003c\/strong\u003e, \u003cstrong\u003elicense recovery\u003c\/strong\u003e, \u003cstrong\u003emedical monitoring\u003c\/strong\u003e, and workplace prevention procedures. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Certified \u003cstrong\u003eCE\u003c\/strong\u003e, compliant with \u003cstrong\u003eISO 13485\u003c\/strong\u003e standard and designed for professional use, it offers a fast, simple, and reliable reading, with a correlation above \u003cstrong\u003e99%\u003c\/strong\u003e with the reference \u003cstrong\u003eGC\/MS\u003c\/strong\u003e method. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDetection of urinary THC-COOH\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eStandard threshold: 50 ng\/mL\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eIdeal for license recovery, workplace, and monitoring\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetection\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eUrinary THC-COOH\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDetected substance\u003c\/h2\u003e \u003cp\u003e The Drugdiag® THC urine test detects \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, the main cannabis metabolite eliminated in urine. It is suitable for situations where the goal is to verify past consumption or abstinence over a longer period than saliva testing. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eUrinary cannabis metabolite\u003c\/strong\u003e, resulting from the breakdown of THC by the body.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eFlowers\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eClassic cannabis\u003c\/strong\u003e, weed, marijuana, pot.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eResin\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eHashish\u003c\/strong\u003e, pollen, cannabis resin.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eConcentrates\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOils, wax, rosin, e-liquids\u003c\/strong\u003e, or concentrated products containing cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eEdibles\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eInfused edible products\u003c\/strong\u003e, cakes, candies, or preparations containing cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCBD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eFull-spectrum CBD products\u003c\/strong\u003e: a positive result is possible if residual THC accumulates.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003ePositive risk\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e This urine test does not directly detect active Δ9-THC in saliva. It detects \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, the urinary metabolite of cannabis, allowing for a longer detection window. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eWarning: CBD and positive result\u003c\/h3\u003e \u003cp\u003e \u003cstrong\u003ePure CBD\u003c\/strong\u003e is not the target of the test. However, some full-spectrum CBD products may contain residual traces of THC. \u003c\/p\u003e \u003cp\u003e In case of regular consumption of flowers, resins, or CBD oils containing residual THC, THC can accumulate and then be eliminated in urine as \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, with a risk of a positive result. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUses\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eLicense, work, monitoring\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eRecommended uses\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eLicense recovery\u003c\/h3\u003e \u003cp\u003e The Drugdiag® THC urine test is especially suitable for self-testing before a medical visit, medical commission, or official analysis. It helps verify if urinary traces of cannabis remain detectable. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eWorkplace safety\u003c\/h3\u003e \u003cp\u003e In the workplace, it can be part of a risk prevention approach for sensitive or security positions, respecting internal regulations, confidentiality, and applicable framework, notably article \u003cstrong\u003eL.4121-1 of the Labor Code\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eMedical monitoring and prevention\u003c\/h3\u003e \u003cp\u003e This test can be used for medical monitoring, support for cannabis cessation, or individual prevention, with a quick and easy-to-interpret result. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eAdvantages of the Drugdiag® THC test\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eLong-lasting urinary detection:\u003c\/strong\u003e detection of THC-COOH, the persistent cannabis metabolite.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eStandard threshold:\u003c\/strong\u003e detection calibrated at 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eVersatile use:\u003c\/strong\u003e license recovery, self-testing, medical monitoring, workplace.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQuick reading:\u003c\/strong\u003e visual result in a few minutes according to the manufacturer’s instructions.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFrench manufacturer:\u003c\/strong\u003e device from the Drugdiag® range by Toda Pharma laboratory.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProfessional quality:\u003c\/strong\u003e in vitro diagnostic medical device with CE marking and ISO 13485 standard.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUsed by the French Armed Forces:\u003c\/strong\u003e UAF label associated with the relevant devices from the Toda Pharma range.\u003c\/li\u003e \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResults\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDetection windows\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUrinary detection windows\u003c\/h2\u003e \u003cp\u003e Unlike the saliva test, which provides information on recent use, the urine test allows identification of past use through detection of \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eOccasional\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eSingle or very occasional use:\u003c\/strong\u003e indicative detection duration generally between 1 and 3 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eIndicative\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eRegular\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMultiple consumptions per week:\u003c\/strong\u003e indicative detection possible between 5 and 12 days depending on profiles.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariable\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eChronic\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eDaily or heavy use:\u003c\/strong\u003e detection possible up to 30 days, sometimes longer in some individuals.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariable\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Detection times are indicative. They vary depending on metabolism, consumption frequency, product concentration, BMI, hydration, and other individual factors. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eNegative result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A negative result indicates that \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e was not detected above the 50 ng\/mL threshold. This does not guarantee the absolute absence of any trace but indicates the test threshold was not reached. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePositive result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A positive result indicates a reaction compatible with the presence of \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e in urine. For any official or disputed procedure, confirmation by a laboratory analytical method is recommended. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eInvalid result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be redone with a new device. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTechnique\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eReliability and quality\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTechnical expertise\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eColloidal gold technology\u003c\/h3\u003e \u003cp\u003e The device uses competitive immunochromatography with colloidal gold-labeled antibodies. This technology allows clear, rapid visual reading suitable for professional use. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eGC\/MS reliability\u003c\/h3\u003e \u003cp\u003e The test accuracy was compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e), showing an accuracy correlation above \u003cstrong\u003e99%\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eQuality compliance\u003c\/h3\u003e \u003cp\u003e Designed by the French laboratory Toda Pharma, this \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is CE marked and complies with the quality standard \u003cstrong\u003eISO 13485\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eMain features\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTest type:\u003c\/strong\u003e rapid-read cannabis urine test.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eTarget substance:\u003c\/strong\u003e THC-COOH, urinary metabolite of cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eDetection threshold:\u003c\/strong\u003e 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e individually packaged urine cassette.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e individually sealed package with user instructions in French on the packaging.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUse:\u003c\/strong\u003e prevention, self-monitoring, medical follow-up, license recovery, and workplace.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eNo cross-reactivity\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eCommon medications:\u003c\/strong\u003e aspirin, ibuprofen, paracetamol, amoxicillin, penicillin, dextromethorphan.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePhysiological and dietary substances:\u003c\/strong\u003e caffeine, cholesterol, hemoglobin, creatinine, vitamin C, uric acid.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e The test must be used according to the manufacturer’s instructions. In case of a positive, doubtful, or contested result, confirmation by laboratory analysis remains the reference. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eFAQ\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFrequently Asked Questions\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eWhat exactly does the Drugdiag® THC urine test detect?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e It detects \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, the main urinary metabolite of cannabis. This metabolite can remain detectable longer than the active THC sought in saliva. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eWhat is the difference with a THC saliva test?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e The saliva test mainly detects active THC over a short window, often related to recent use. The urine test detects THC-COOH, which can remain present longer in the body. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eIs this test suitable for license recovery?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes. It is particularly useful for self-monitoring before a medical visit or official analysis, as it allows checking if THC-COOH remains detectable in urine. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eCan CBD cause this test to be positive?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes, in some cases. Pure CBD is not the target of the test, but CBD products containing residual traces of THC can cause a positive result, especially with regular use. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eHow long does cannabis remain detectable in urine?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e The duration depends on the consumption profile. It can be about 1 to 3 days for occasional use, 5 to 12 days for regular use, and up to 30 days or more for some chronic users. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eDoes a positive result have definitive legal value?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e No. A positive result on a rapid test is a preliminary result. For any official procedure, confirmation by laboratory analytical method is required. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003eNeed advice or a quote for a professional order?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Request a quote \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eLegal notice:\u003c\/strong\u003e This test is an \u003ci\u003ein vitro\u003c\/i\u003e diagnostic device intended to indicate the presence of \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e in urine. A preliminary positive result indicates the possible presence of cannabis metabolites but does not constitute definitive legal proof. Confirmation by laboratory analytical method is recommended for any official procedure. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"Pack of 5","offer_id":56426433904964,"sku":"1041-THC","price":29.95,"currency_code":"EUR","in_stock":true},{"title":"Pack of 10","offer_id":56426433937732,"sku":"1041-THC","price":56.91,"currency_code":"EUR","in_stock":true},{"title":"Pack of 25","offer_id":56426433970500,"sku":"1041-THC","price":127.29,"currency_code":"EUR","in_stock":true},{"title":"1 unit","offer_id":56426433872196,"sku":"1041-THC","price":5.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Image_produit_Drgdiag_THC.png?v=1777887804"},{"product_id":"test-urinaire-cassette-11-drogues","title":"11-Drug Urine Test Drugdiag® 11","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 11 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003e11-drug urine test\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® 11: broad-spectrum multi-drug urine test \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e The \u003cstrong\u003eDrugdiag® 11 drugs urine test\u003c\/strong\u003e, developed by the French laboratory \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, the leader in rapid diagnostic tests, allows \u003cstrong\u003esimultaneous detection of 11 drug families\u003c\/strong\u003e in urine. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e It notably detects \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eamphetamines\u003c\/strong\u003e, \u003cstrong\u003ebarbiturates\u003c\/strong\u003e, \u003cstrong\u003ebenzodiazepines\u003c\/strong\u003e, \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e, \u003cstrong\u003ecocaine\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003emethamphetamines\u003c\/strong\u003e, \u003cstrong\u003eopiates\u003c\/strong\u003e, \u003cstrong\u003emethadone\u003c\/strong\u003e, and \u003cstrong\u003etricyclic antidepressants\u003c\/strong\u003e. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e This multi-drug test is particularly suited for \u003cstrong\u003ebusinesses\u003c\/strong\u003e, \u003cstrong\u003eoccupational physicians\u003c\/strong\u003e, \u003cstrong\u003eaddiction treatment centers\u003c\/strong\u003e, \u003cstrong\u003ehealth professionals\u003c\/strong\u003e, and organizations that need to secure environments with high levels of responsibility. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eSimultaneous detection of 11 families\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRapid-read urine format\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUse in business, health, and addiction treatment\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetection\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e11 targeted families\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDetected substances\u003c\/h2\u003e \u003cp\u003e The Drugdiag® 11 urine test allows broad screening of the main families of psychoactive substances, including both the most common narcotics, certain psychoactive medications, and molecules used in addiction monitoring. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e main metabolite of THC, associated with consumption of cannabis, resin, flowers, or products containing THC.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e amphetamine-type stimulants, speed, and related substances.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturates:\u003c\/strong\u003e family of central nervous system depressants.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepines:\u003c\/strong\u003e anxiolytics, hypnotics, or sedatives that can impair alertness.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e molecule used notably in some opioid substitution treatments.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e cocaine, crack, and related metabolites detectable in urine.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA and related substances.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e crystal meth, ice, and related derivatives.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e morphine, heroin, opium, and related compounds.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethadone:\u003c\/strong\u003e molecule used notably in some opioid substitution treatments.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eTricyclic antidepressants:\u003c\/strong\u003e family of psychoactive drugs sought in certain clinical contexts.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Thresholds must be interpreted according to the manufacturer’s instructions, clinical or professional context, and screening objectives. In case of a positive result, laboratory confirmation may be necessary depending on the context. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUses\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eBusiness, health, safety\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eMain uses\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eSensitive positions and high-risk sectors\u003c\/h3\u003e \u003cp\u003e The Drugdiag® 11 is particularly suited for security and safety positions: transport, logistics, construction, heavy industry, maintenance of sensitive installations, energy, classified sites, or high-responsibility environments. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTherapeutic monitoring and addiction medicine\u003c\/h3\u003e \u003cp\u003e Thanks to the detection of \u003cstrong\u003emethadone\u003c\/strong\u003e, \u003cstrong\u003ebuprenorphine\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e, this test can be useful for CSAPA, doctors, psychiatrists, clinics, and detox centers to document follow-up, complementing clinical interviews. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eWorkplace prevention\u003c\/h3\u003e \u003cp\u003e When provided for in internal regulations, this test can be integrated into an internal prevention procedure: targeted control, risk situation, accident, incident, or overall safety approach. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eResponsible self-monitoring\u003c\/h3\u003e \u003cp\u003e The Drugdiag® 11 can also be used by individuals for self-monitoring before a medical appointment, professional visit, or administrative procedure. Laboratory confirmation remains necessary in any official context. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eAdvantages of the Drugdiag® 11 test\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eExtended detection:\u003c\/strong\u003e 11 substance families detected in a single analysis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eVersatile tool:\u003c\/strong\u003e companies, occupational health, addiction medicine, medico-social structures, institutions, and self-monitoring.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQuick reading:\u003c\/strong\u003e visual result in minutes according to the manufacturer’s instructions.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFrench manufacturer:\u003c\/strong\u003e device from the Drugdiag® range by Toda Pharma laboratory.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProfessional quality:\u003c\/strong\u003e CE marking, ISO 13485 quality environment, and batch traceability.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eAddiction monitoring:\u003c\/strong\u003e BUP, MTD, and TCA panels useful in certain medical contexts.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePrevention policy:\u003c\/strong\u003e integrable into a comprehensive approach of information, training, and support.\u003c\/li\u003e \u003c\/ul\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eRegulated use in companies\u003c\/h3\u003e \u003cp\u003e In the workplace, the use of screening tests must be provided for in the internal regulations, justified by the nature of the tasks, and implemented in compliance with the Labor Code, employee rights, and confidentiality. \u003c\/p\u003e \u003cp\u003e The Drugdiag® 11 test is part of a comprehensive prevention policy and never replaces clinical evaluation or confirmatory laboratory analyses when required. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResults\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eUrine durations\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUrine detection times\u003c\/h2\u003e \u003cp\u003e The detection time of substances in urine depends on many factors: frequency of use, quantity, metabolism, health status, kidney function, hydration, ongoing treatment, and length of use. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e indicative duration highly variable depending on frequency and intensity of use.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 30 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmphetamines:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturates:\u003c\/strong\u003e indicative duration varies depending on the molecule, dose, and usage.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 5 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepines:\u003c\/strong\u003e indicative duration varies and can be longer with prolonged treatment.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7+ days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorphine:\u003c\/strong\u003e indicative duration varies depending on dose, frequency, and treatment duration.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaine:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e indicative duration generally between 1 and 3 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 3 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethamphetamines:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiates:\u003c\/strong\u003e indicative duration generally between 1 and 4 days.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 4 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMethadone:\u003c\/strong\u003e indicative duration varies depending on the therapeutic regimen.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eTricyclic antidepressants:\u003c\/strong\u003e indicative duration varies depending on the molecule and dosage.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 to 7 days\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e These detection windows are indicative and can never serve as absolute proof of consumption or abstinence. They must be interpreted according to the clinical context, the person’s statements, and, if necessary, additional examinations. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eNegative result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A negative result indicates that the targeted drug families were not detected above the test thresholds. This does not guarantee the absolute absence of any substance. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePositive result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A positive result indicates a reaction compatible with the presence of one or more targeted drug families in the urine. Laboratory confirmation is recommended in any official, medical, disciplinary, or disputed context. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eInvalid result\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e An invalid result may be due to incorrect handling, insufficient sample volume, or failure to respect the reading time. In this case, the test should be repeated with a new device. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTechnique\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQuality and reliability\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTechnical expertise\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eColloidal gold technology\u003c\/h3\u003e \u003cp\u003e The device uses competitive immunochromatography with colloidal gold-labeled antibodies, allowing clear, rapid reading suitable for professional use. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eGC\/MS reliability\u003c\/h3\u003e \u003cp\u003e The accuracy of this professional urine screening device has been compared to the laboratory reference method, gas chromatography coupled with mass spectrometry (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e). \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eQuality compliance\u003c\/h3\u003e \u003cp\u003e Designed by the French laboratory Toda Pharma, this \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is CE marked, complies with the \u003cstrong\u003eISO 13485\u003c\/strong\u003e quality standard, and offers full batch traceability. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eMain features\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTest type:\u003c\/strong\u003e rapid-read multi-drug urine test.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstances tested:\u003c\/strong\u003e THC-COOH, AMP, BAR, BZO, BUP, COC, MDMA, MET, MOP, MTD, TCA.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e easy-to-use urine test with visual reading of result strips.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUse:\u003c\/strong\u003e professional prevention, occupational medicine, addiction treatment, therapeutic monitoring, self-monitoring.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e French laboratory Toda Pharma, the number 1 in rapid diagnostic testing.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e in vitro diagnostic medical device with CE marking and ISO 13485 certification.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eNo cross-reactivity\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eCommon medications:\u003c\/strong\u003e aspirin, ibuprofen, paracetamol, amoxicillin, penicillin, dextromethorphan.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePhysiological and dietary substances:\u003c\/strong\u003e caffeine, cholesterol, hemoglobin, creatinine, vitamin C, uric acid.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e The test must be used according to the manufacturer's instructions. In case of a positive, doubtful, or disputed result, confirmation by laboratory analysis is still recommended. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eFAQ\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFrequently Asked Questions\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eWhat does the Drugdiag® 11 urine test detect?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e It detects 11 families of substances in urine: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eWho is this test for?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e It is intended for companies, occupational physicians, addiction centers, healthcare professionals, organizations exposed to security risks, and individuals wishing to perform responsible self-monitoring. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eIs this test suitable for addiction monitoring?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes. The \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e, and \u003cstrong\u003eTCA\u003c\/strong\u003e panels, combined with other targeted families, can be useful in certain therapeutic or addiction follow-ups, complementing clinical evaluation. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eCan it be used in the workplace?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Yes, if its use is provided for by internal regulations, justified by the nature of the tasks, proportionate to the risk, and implemented in compliance with the Labor Code, employee rights, and confidentiality. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eDoes a positive result have definitive value?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e No. A rapid test provides a preliminary analytical result. In any official, judicial, administrative, disciplinary, medical, or disputed context, confirmation by laboratory analytical method is recommended. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003eNeed advice or a quote for a professional order?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Request a quote \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eLegal notice:\u003c\/strong\u003e This \u003ci\u003ein vitro\u003c\/i\u003e diagnostic medical device is intended for professional use and, where applicable, responsible personal use, in compliance with current French and European legislation. It provides a preliminary analytical result and does not replace a confirmatory laboratory analysis within the framework of judicial, administrative, medical, disciplinary, or disputed procedures. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unit","offer_id":56426434199876,"sku":"10411","price":14.94,"currency_code":"EUR","in_stock":true},{"title":"Pack of 5","offer_id":56426434232644,"sku":"10411","price":74.7,"currency_code":"EUR","in_stock":true},{"title":"Pack of 10","offer_id":56426434265412,"sku":"10411","price":141.93,"currency_code":"EUR","in_stock":true},{"title":"Pack of 25","offer_id":56426434298180,"sku":"10411","price":317.47,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_Poduit_du_drugdiag_11.png?v=1777888364"}],"url":"https:\/\/ama-prevention.com\/collections\/toda-drugdiag-cassette.oembed","provider":"AMA Prévention ","version":"1.0","type":"link"}